SH PHARMA(02607) Stock Price Today | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Earnings Preview: SH PHARMA to Report Financial Results on April 28
Moomoo NewsApr 29 05:45 ET
Shanghai Pharmaceuticals: Report of Shanghai Pharmaceutical Group Co., Ltd. for the first quarter of 2025
SZSIApr 28 12:00 ET · Announcements
Shanghai Pharmaceutical Group Co., Ltd. Report for the first quarter of 2025
SZSIApr 28 12:00 ET · Announcements
Shanghai Pharmaceuticals' Q1 Profit Slides 14%
MT NewswiresApr 28 09:05 ET
Express News | Shanghai Pharmaceuticals - Qtrly Net Profit Attributable RMB1.33 Bln
ReutersApr 28 05:01 ET
SH PHARMA: 2025 FIRST QUARTERLY REPORT
HKEXApr 28 05:00 ET · Announcements

Comments

Moomoo AI

Feb 21, 2024 12:29

The company's consistent ROCE and capital increase hint at a lack of high return investments. High current liabilities to total assets ratio may pose risks. The stock's low return to shareholders over the past five years shows lackluster trends.

Return Trends At Shanghai Pharmaceuticals Holding (SHSE:601607) Aren't Appealing

Moomoo AI

Dec 18, 2023 08:39

Shanghai Pharmaceuticals Holding's declining earnings and anticipated lower growth may signal a less prosperous future. This, combined with a lack of earnings growth improvement, could prevent a significant share price increase in the near term.

Shanghai Pharmaceuticals Holding Co., Ltd's (SHSE:601607) Prospects Need A Boost To Lift Shares

Moomoo AI

Nov 30, 2023 09:44

The market may have anticipated the fall in EPS, or it might expect the situation to get better. Dividend payments largely explain the divergence between the TSR and share price return over five years. Significant improvement in fundamental performance is needed to reverse the downward trend in the stock value.

Shanghai Pharmaceuticals Holding (SHSE:601607) Investors Are Sitting on a Loss of 2.5% If They Invested Five Years Ago

Moomoo AI

Nov 12, 2023 08:43

The company's poor and stagnant return on capital invested, the surge in capital used, and the significant short-term debt obligations suggest a lackluster performance. It doesn't exhibit the traits of a prospective multi-bagger stock.

Returns On Capital At Shanghai Pharmaceuticals Holding (SHSE:601607) Have Stalled

02607 SH PHARMA

Trade Overview

Capital Trend

News

Comments

Market Insights

Market Headlines

Latest News